Illumina第四季度收入指引令人失望，股价盘后下跌2%
Illumina(NASDAQ:ILMN) 公布的第三季度盈利超过分析师预期，但由于公司第四季度收入指引低于预期，盘后交易中股价下跌2%。
这家基因测序公司报告的调整后每股收益为1.14美元，超过了0.88美元的共识预期。季度收入为10.8亿美元，与分析师预测一致。
然而，Illumina对第四季度的展望令投资者失望。公司预计第四季度收入约为10.7亿美元，低于分析师预测的11.5亿美元。
对于2024全年，Illumina下调了收入指引，现预计核心Illumina收入与2023财年相比将下降约3%。公司将下调展望归因于近期宏观经济环境受限。
首席执行官Jacob Thaysen表示："Illumina产品和应用的潜在需求仍然强劲，我们在推动利润率和盈利扩张方面正在取得显著进展。"
从积极方面来看，Illumina上调了全年调整后每股收益指引至4.05美元至4.15美元区间，高于3.91美元的共识预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10